drugset / Trial / NCT00254085

Substitution of First Phase Insulin Response in Patient With Type 2 Diabetes.

NCT00254085

Phase 4 Unknown 20 enrolled University Hospital, Gentofte, Copenhagen
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of the project is to shown whether a little dose of a short acting insulin analogue given 3 time daily before the meals compared with placebo could normalise the increase in blood glucose after teh meals in diet treated Type 2 diabetic patients.

Timeline

Start
2005-03
Primary completion
Completion
2006-03

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin aspart Protein / enzyme biologic 0.06 iu/kg